| Emily Maughon, PHARMD | |
|
3014 Allison Bonnett Memorial Dr Ste 130, Hueytown, AL 35023-2395 | |
| (205) 497-5372 | |
| Not Available |
| Full Name | Emily Maughon |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3014 Allison Bonnett Memorial Dr Ste 130, Hueytown, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245885136 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 21104 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Emily Maughon, PHARMD 412 Park Rd, Pleasant Grove, AL 35127-1859 Ph: (205) 260-7662 | Emily Maughon, PHARMD 3014 Allison Bonnett Memorial Dr Ste 130, Hueytown, AL 35023-2395 Ph: (205) 497-5372 |
News Archive
University of South Florida researchers have identified a genetic biomarker for age-related hearing loss, a major breakthrough in understanding and preventing a condition of aging that affects 30 million Americans and greatly diminishes their quality of life.
David Morris of Alexandria, Virginia has a fascinating job that takes him all over the world. So when arthritis and unrelenting knee pain put a crimp in his active lifestyle, he thought it was time to consider knee replacement.
On Veteran's Day the University of Connecticut announced the launch of its new grand research challenge: regeneration of a human knee within 7 years, and an entire limb within 15 years.
Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for under-served medical needs in neurology and cardiology, announced the completion of the interim analysis of the pivotal efficacy study of olesoxime in the rare neurodegenerative condition Spinal Muscular Atrophy (SMA).
Talecris Biotherapeutics, Inc. announced today the initiation of a clinical trial evaluating the safety and the pharmacokinetic profile of two doses of PROLASTIN®-C (Alpha(1)-Proteinase Inhibitor [Human]) (A1PI), a therapy indicated for chronic augmentation and maintenance in adults with emphysema due to alpha(1)-antitrypsin (AAT) deficiency. AAT deficiency is a rare, genetic disorder in which low levels of the alpha(1) protein circulating in the lungs can increase an individual's risk of developing emphysema.
› Verified 3 days ago
Dr. Daniel Ray Vines, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1280 Hueytown Rd, Hueytown, AL 35023 Phone: 205-491-2805 | |
Spencer Stephens, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2600 15th Street Rd, Hueytown, AL 35023 Phone: 205-425-4595 Fax: 205-425-0701 | |
Mrs. Rebecca Ann Dennis, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 104 River Square Plaza, Hueytown, AL 35023 Phone: 205-491-3889 | |
Katie Manderson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3014 Allison Bonnett Memorial Dr, Hueytown, AL 35023 Phone: 205-497-5372 | |
William Andrew White, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3025 Allison Bonnett Memorial Dr, Hueytown, AL 35023 Phone: 205-744-9972 | |
Tiana Pisoni, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3018 Allison Bonnett Memorial Dr, Hueytown, AL 35023 Phone: 205-744-0071 |